C3P1: A Protein Implicated in Cancer and Many Other Diseases (G388503)

Target Name: C3P1

NCBI ID: G388503

C3P1

Other Name(s): CPLP | Complement component 3 precursor pseudogene | complement component 3 precursor pseudogene

C3P1: A Protein Implicated in Cancer and Many Other Diseases

C3P1, also known as CPLP, is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell-cell adhesion and has been implicated in a number of diseases, including cancer.

One of the key functions of C3P1 is its role in cell-cell adhesion. This protein helps to ensure that cells stick together and form tissues, which is essential for many biological processes, including growth, development, and repair.

C3P1 is also involved in the regulation of cell signaling pathways. It has been shown to play a role in a number of signaling pathways that are important for cancer progression, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is often disrupted in cancer.

In addition to its role in cell-cell adhesion and signaling pathways, C3P1 has also been shown to play a role in the regulation of cellular processes that are important for the development and maintenance of tissues. This protein has been shown to be involved in the regulation of cell division, cell migration, and the formation of tissues.

Given its involvement in a number of important biological processes, C3P1 has been identified as a potential drug target or biomarker. Researchers are currently working to develop compounds that can specifically target C3P1 and inhibit its activity. These compounds have the potential to be used to treat a wide range of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

In conclusion, C3P1 is a protein that is involved in a number of important biological processes and has been implicated in a number of diseases. Its potential as a drug target or biomarker makes it an attractive target for research into the treatment of a wide range of conditions. Further research is needed to fully understand the role of C3P1 in biology and to develop effective treatments.

Protein Name: Complement Component 3 Precursor Pseudogene

The "C3P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C3P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets